Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Marshall, Gerstein & Borun Partners Heather R. Kissling and Katherine L. Neville, Ph.D., Selected Among 2016 Women Worth Watching

Marshall,Gerstein & Borun LLP
Posted on: 17 Oct 16

Marshall, Gerstein & Borun LLP is pleased to announce that partners Heather R. Kissling and Katherine L. Neville, Ph.D., have been recognized in the 2016 Women Worth Watching® list by Profiles in Diversity Journal. The women recognized by the journal were nominated by their colleagues, peers, and mentors for their initiative and achievements. The list highlights women who are using their influence to change our workplaces and our world. To visit Ms. Kissling’s profile, click here. To visit Dr. Neville’s profile, click here.

This Smart News Release features multimedia. View the full release here:

Marshall Gerstein partner Heather Kissling has been recognized among the 2016 Women Worth Watching by Profiles in Diversity Journal. (Photo: Business Wire)

“We are extremely proud of the leadership that Heather and Kate demonstrate both inside and outside the Firm,” said Managing Partner Jeff Sharp. “They are both incredibly talented and dedicated, and we are grateful to have them on our team,” he added.

Ms. Kissling draws from over 15 years of experience securing biotechnology patents to develop worldwide filing and prosecution strategies that further her clients’ business objectives. Clients find her to be a forward-thinking advocate that shares their commitment to realizing the maximum value from their intellectual property assets. Ms. Kissling is chair of the Firm’s Biotechnology & Life Sciences practice group; serves on the Firm’s Professional Development and Orientation Committee; and formally mentors two female associates. She was selected to the 2014 and 2016 editions of Managing IP’s IP Stars list of the Top 250 Women in IP.

For more than 15 years, Dr. Neville, a partner in the firm’s biotechnology practice group, has called on her experience to counsel clients in strategic management of worldwide patent rights, relying on her background prosecuting domestic and foreign patents, providing due diligence analyses, handling interference, reexamination, and opposition proceedings, as well as giving non-infringement, patentability, freedom to operate, and validity opinions. Dr. Neville is a member of the Firm’s Recruiting Committee and Marketing & Business Development Committee; and is a mentor for Firm associates. In recognition of her outstanding patent work in life sciences, Dr. Neville has been featured as a "Life Sciences Star" in the 2015 edition of LMG Life Sciences.

About Marshall, Gerstein & Borun LLP

Marshall, Gerstein & Borun LLP is exclusively focused on intellectual property law. Nearly half of the Firm’s professionals have been general counsel to the private, governmental, or university sectors, patent counsel, technology transfer managers, scientists, engineers, or consultants. Chambers & Partners has ranked Marshall, Gerstein & Borun as “first-rate for litigation,” and having “one of the best biotechnology practices in the entire country.” Corporate Counsel magazine lists the Firm as a “Go-To Law Firm of the Top 500 Companies” for intellectual property and litigation. The Firm also is ranked as a top intellectual property law firm by Managing IP, Fortune, Intellectual PropertyToday, and Intellectual Asset Management magazines.

View source version on

Business Wire

Last updated on: 17/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.